+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Targeted Therapies"

Gene Delivery Technologies Market - Product Thumbnail Image

Gene Delivery Technologies Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Adeno Associated Virus Vector Manufacturing Market - Product Thumbnail Image

Adeno Associated Virus Vector Manufacturing Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
From
Thematic Intelligence: Microbiome-Based Therapeutics - Product Thumbnail Image

Thematic Intelligence: Microbiome-Based Therapeutics

  • Report
  • August 2024
  • 62 Pages
  • Global
From
From
Cloning and Mutagenesis Market Report and Forecast 2024-2032 - Product Thumbnail Image

Cloning and Mutagenesis Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 200 Pages
  • Global
From
Personalised Medicine Market Report and Forecast 2024-2032 - Product Thumbnail Image

Personalised Medicine Market Report and Forecast 2024-2032

  • Report
  • July 2024
  • 200 Pages
  • Global
From
Pyrosequencing Market Report and Forecast 2024-2032 - Product Thumbnail Image

Pyrosequencing Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 200 Pages
  • Global
From
From
Gene Expression Market Report and Forecast 2024-2032 - Product Thumbnail Image

Gene Expression Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 140 Pages
  • Global
From
Innovation Insights: Engineered Exosomes - Product Thumbnail Image

Innovation Insights: Engineered Exosomes

  • Report
  • January 2025
  • 50 Pages
  • Global
From
Innovation Insights: siRNA gene silencing - Product Thumbnail Image

Innovation Insights: siRNA gene silencing

  • Report
  • January 2025
  • 53 Pages
  • Global
From
From
From
Loading Indicator

The Targeted Therapies market within the context of Genomics is focused on the development of treatments that target specific genetic mutations or pathways. These therapies are designed to be more effective and have fewer side effects than traditional treatments. Genomics has enabled the development of personalized treatments that are tailored to the individual patient's genetic makeup. This has allowed for the development of drugs that target specific mutations or pathways, leading to more effective treatments. The Targeted Therapies market is a rapidly growing field, with many companies investing in research and development. Companies such as Gilead Sciences, Novartis, and AstraZeneca are leading the way in the development of targeted therapies. Other companies such as Merck, Pfizer, and Roche are also investing in the development of targeted therapies. Show Less Read more